$ITRM

Iterum Therapeutics Plc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$0.244 ▼-0.041%

Extented Hours

VOLUME

1,871,778

DAY RANGE

0.232 - 0.2698

52 WEEK

0.175 - 0.7612

Join Discuss about ITRM with like-minded investors

profile
@achatzi #ivtrades
recently

$LCID , $ITRM , $SQQQ , (sold some calls @40 Jan23)

111 Replies 11 👍 14 🔥

profile
@Gary19 #droscrew
recently

its their fault to be honest,look at $aht and $itrm. ppl went bankrupt following

66 Replies 15 👍 6 🔥

profile
@Chano #StockTraders.NET
recently

$ITRM squeezing

61 Replies 14 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

I didn't trade it... I just traded 3 names $SNDL, $HTBX & $ITRM

112 Replies 8 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

$ITRM nice too have a 2.71 avg

79 Replies 6 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

$SNDL, $GSAT, $ITRM nice traders today

92 Replies 11 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

covered the $ITRM flat

80 Replies 10 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

starting a small short again on $ITRM

123 Replies 13 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

$itrm going again

66 Replies 10 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

$ITRM was to easy

134 Replies 8 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

ITRM 2.62 was my highest short

66 Replies 8 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

$ITRM & $HTBX were my main trades

123 Replies 8 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

and $ITRM too

70 Replies 10 👍 13 🔥

profile
@Neptune5045 #StockTraders.NET
recently

I'm short $ITRM

50 Replies 10 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

watch list: $CTIC, $WWR, $NKLA, $SRNE, $SUNW, $ITRM, $DOCU, $SHLL, $NNDM if the borrow is available tomorrow.

76 Replies 6 👍 14 🔥

AN
@andres168 #StockTraders.NET
recently

$itrm congrats

86 Replies 14 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

covered some $ITRM 1.34

79 Replies 14 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

covered half of $ITRM

116 Replies 9 👍 14 🔥

profile
@Math #StockTraders.NET
recently

ITRM covered 1/2

42 Replies 8 👍 7 🔥

profile
@Math #StockTraders.NET
recently

farmer chased on ITRM and trapped followers

98 Replies 13 👍 15 🔥

profile
@TraderXx #StockTraders.NET
recently

$ITRM about to open at 1.5 yuck

42 Replies 8 👍 12 🔥

profile
@TraderXx #StockTraders.NET
recently

My borrows for $ITRM out the window, what was I thinking... I knew this will be the case

98 Replies 8 👍 9 🔥

profile
@TraderXx #StockTraders.NET
recently

next key lvls on $ITRM: 2.2, 2.5 , 3 , 3.4 , 4

101 Replies 7 👍 6 🔥

profile
@TraderXx #StockTraders.NET
recently

$ITRM could get almost untradable due to halts, if it stays crowded

61 Replies 7 👍 10 🔥

profile
@TraderXx #StockTraders.NET
recently

$ITRM let the halt fest begin

56 Replies 13 👍 15 🔥

profile
@TraderXx #StockTraders.NET
recently

$ITRM PM volume suggests t will be crowded day on this name

74 Replies 12 👍 15 🔥

WI
@WINTERTRADE #StockTraders.NET
recently

ITRM nice one

120 Replies 11 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

$ITRM was a nice one

71 Replies 14 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

$ITRM is moving

66 Replies 9 👍 14 🔥

Key Metrics

Market Cap

46.30 M

Beta

1.26

Avg. Volume

9.64 M

Shares Outstanding

183.35 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-12

Next Dividend Date

Company Information

Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterum Therapeutics is advancing its first compound, sulopenem, a novel penem anti-infective compound, in Phase 3 clinical development with an oral formulation and IV formulation. Sulopenem has demonstrated potent in vitro activity against a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. Iterum Therapeutics has received Qualified Infectious Disease Product (QIDP) and Fast Track designations for its oral and IV formulations of sulopenem in seven indications.

Website:

HQ: ,

Related News